Premium
Multicenter evaluation of efficacy and toxicity of venetoclax‐based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
Author(s) -
King Amber C.,
Weis Taylor M.,
Derkach Andriy,
Ball Somedeb,
Pandey Manu,
Mauro Michael J.,
Goldberg Aaron D.,
Stahl Maximilian,
Famulare Christopher,
Tallman Martin S.,
Wang Eunice S.,
Kuykendall Andrew T.,
Rampal Raajit K.
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26381
Subject(s) - venetoclax , medicine , toxicity , myelofibrosis , oncology , multicenter study , leukemia , bone marrow , randomized controlled trial , chronic lymphocytic leukemia